arrow
L

Lesley A. Inker

tufts medical center
H指数:78
被引数:5.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Addendum: A meta-analysis of GFR slope as a surrogate endpoint for kidney failure

补充:GFR斜率作为肾衰竭替代终点的荟萃分析

2026-11-160
PRE
An individual patient meta-analysis assessed the associations between change in albuminuria and acute changes in the glomerular filtration rate in randomized controlled trials of chronic kidney disease progression

一项个体患者Meta分析评估了慢性肾病进展的随机对照试验中,白蛋白尿变化与肾小球滤过率急性变化之间的关联

2026-09-300
PRE
A meta-analysis of albuminuria as a surrogate endpoint for kidney failure

白蛋白尿作为终末期肾病替代终点的荟萃分析

2025-11-060
PRE
A Target Trial Emulation Study of SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Combination Therapy in Preventing Kidney Failure in Type 2 Diabetes

一项关于SGLT2抑制剂、GLP-1受体激动剂及联合疗法预防2型糖尿病肾衰竭的目标试验模拟研究

2025-11-010
PRE
Association between baseline serum creatinine/cystatin C (SCr/CYS) ratio and adverse events in patients receiving cisplatin or carboplatin: a prospective cohort study

基线血清肌酐/胱抑素C (SCr/CYS) 比值与接受顺铂或卡铂治疗患者不良事件的相关性:一项前瞻性队列研究

2025-10-010
OAAI
Accuracy of GFR estimating equations based on creatinine, cystatin C or both in people with underweight or obesity: the Stockholm CREAtinine Measurements (SCREAM) project

基于肌酐、胱抑素C或两者估算的GFR方程在体重不足或肥胖人群中的准确性:斯德哥尔摩CREAtinine Measurements (SCREAM) 项目

2025-10-010
OAAI
A Strategic Roadmap to Support Communication on and Acceptance of Surrogate Endpoints: The REnal Surrogacy accEpTance in Chronic Kidney Disease (RESET CKD) Collaboration

支持慢性肾病替代终点沟通与接受的战略路线图:慢性肾病替代终点接受度(RESET CKD)合作

2025-09-230
OAAI
Impact of Computed Tomography-Derived Body Composition Analysis on the Performance of GFR Estimating Equations in Patients with Cancer

计算机断层扫描衍生的体成分分析对癌症患者肾小球滤过率估算方程性能的影响

2025-09-010
PRE